Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tissue Engineering | 11 | 2023 | 134 | 3.690 |
Why?
|
Peripheral Nerve Injuries | 5 | 2025 | 12 | 3.630 |
Why?
|
Models, Biological | 19 | 2024 | 1141 | 3.520 |
Why?
|
Nerve Regeneration | 6 | 2025 | 31 | 2.350 |
Why?
|
Models, Theoretical | 8 | 2023 | 258 | 2.300 |
Why?
|
Bioreactors | 8 | 2019 | 34 | 1.940 |
Why?
|
Microvessels | 4 | 2024 | 17 | 1.720 |
Why?
|
Peripheral Nerves | 5 | 2024 | 28 | 1.690 |
Why?
|
Algorithms | 6 | 2024 | 998 | 1.550 |
Why?
|
Oxygen | 7 | 2022 | 309 | 1.490 |
Why?
|
Models, Cardiovascular | 5 | 2024 | 77 | 1.480 |
Why?
|
Cell Culture Techniques | 6 | 2021 | 178 | 1.290 |
Why?
|
Microcirculation | 3 | 2020 | 51 | 1.270 |
Why?
|
Collagen | 4 | 2024 | 119 | 1.220 |
Why?
|
Sciatic Nerve | 2 | 2025 | 23 | 1.210 |
Why?
|
Computer Simulation | 10 | 2024 | 458 | 1.160 |
Why?
|
Rats | 11 | 2025 | 1918 | 1.060 |
Why?
|
Imaging, Three-Dimensional | 3 | 2024 | 272 | 1.030 |
Why?
|
Elastic Modulus | 3 | 2024 | 36 | 1.010 |
Why?
|
Neoplasms | 5 | 2024 | 1258 | 0.920 |
Why?
|
Blood Pressure | 3 | 2024 | 522 | 0.920 |
Why?
|
Stress, Mechanical | 6 | 2024 | 111 | 0.910 |
Why?
|
Tissue Culture Techniques | 2 | 2021 | 31 | 0.880 |
Why?
|
Biological Phenomena | 1 | 2022 | 4 | 0.800 |
Why?
|
Ventilators, Mechanical | 2 | 2021 | 31 | 0.770 |
Why?
|
Software | 1 | 2025 | 373 | 0.760 |
Why?
|
Biological Transport | 3 | 2021 | 288 | 0.730 |
Why?
|
Shock | 1 | 2020 | 31 | 0.720 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 200 | 0.710 |
Why?
|
Research Design | 1 | 2023 | 569 | 0.680 |
Why?
|
Retinal Degeneration | 1 | 2020 | 28 | 0.670 |
Why?
|
Global Health | 1 | 2021 | 164 | 0.670 |
Why?
|
Drug Therapy | 1 | 2020 | 61 | 0.660 |
Why?
|
Shock, Septic | 1 | 2020 | 90 | 0.660 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 143 | 0.640 |
Why?
|
Animals | 22 | 2025 | 19717 | 0.640 |
Why?
|
Rheology | 3 | 2019 | 67 | 0.600 |
Why?
|
Disease Models, Animal | 2 | 2024 | 2079 | 0.580 |
Why?
|
Humans | 40 | 2024 | 59810 | 0.550 |
Why?
|
Shear Strength | 3 | 2019 | 15 | 0.550 |
Why?
|
Pandemics | 2 | 2021 | 623 | 0.540 |
Why?
|
Delivery of Health Care | 1 | 2021 | 423 | 0.540 |
Why?
|
Tissue Scaffolds | 5 | 2022 | 80 | 0.540 |
Why?
|
Actins | 1 | 2018 | 257 | 0.530 |
Why?
|
Vascular Neoplasms | 2 | 2020 | 15 | 0.510 |
Why?
|
Cell Lineage | 2 | 2014 | 249 | 0.500 |
Why?
|
Hydrogels | 3 | 2021 | 107 | 0.470 |
Why?
|
Membranes, Artificial | 1 | 2014 | 46 | 0.460 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 647 | 0.460 |
Why?
|
Cells | 1 | 2014 | 30 | 0.460 |
Why?
|
Continuous Positive Airway Pressure | 3 | 2021 | 29 | 0.410 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2024 | 638 | 0.400 |
Why?
|
Extracellular Matrix | 2 | 2024 | 131 | 0.380 |
Why?
|
Chemotaxis | 2 | 2024 | 47 | 0.340 |
Why?
|
Computational Biology | 2 | 2024 | 331 | 0.340 |
Why?
|
Capillaries | 3 | 2024 | 30 | 0.330 |
Why?
|
Brain | 1 | 2018 | 1492 | 0.330 |
Why?
|
Cell Proliferation | 5 | 2017 | 942 | 0.320 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2019 | 96 | 0.310 |
Why?
|
Morphogenesis | 1 | 2009 | 113 | 0.300 |
Why?
|
Blastocyst | 1 | 2009 | 76 | 0.300 |
Why?
|
Mathematical Concepts | 3 | 2020 | 4 | 0.300 |
Why?
|
Hemodynamics | 2 | 2020 | 235 | 0.290 |
Why?
|
Hydrodynamics | 3 | 2018 | 33 | 0.280 |
Why?
|
Endocytosis | 2 | 2021 | 148 | 0.280 |
Why?
|
Biomechanical Phenomena | 3 | 2024 | 246 | 0.270 |
Why?
|
Eyelids | 2 | 2017 | 7 | 0.260 |
Why?
|
Cell Survival | 2 | 2020 | 557 | 0.250 |
Why?
|
Biocompatible Materials | 3 | 2021 | 141 | 0.250 |
Why?
|
Rats, Sprague-Dawley | 2 | 2024 | 571 | 0.240 |
Why?
|
Oxygen Consumption | 3 | 2019 | 203 | 0.230 |
Why?
|
Mice | 5 | 2024 | 10305 | 0.230 |
Why?
|
Retinal Vessels | 1 | 2024 | 18 | 0.230 |
Why?
|
Placenta | 1 | 2024 | 60 | 0.230 |
Why?
|
Diagnostic Imaging | 2 | 2022 | 242 | 0.230 |
Why?
|
Prostheses and Implants | 2 | 2014 | 63 | 0.220 |
Why?
|
Regional Blood Flow | 3 | 2020 | 108 | 0.220 |
Why?
|
Retina | 1 | 2024 | 119 | 0.220 |
Why?
|
Uncertainty | 1 | 2023 | 32 | 0.220 |
Why?
|
Biophysics | 1 | 2023 | 43 | 0.220 |
Why?
|
Machine Learning | 1 | 2025 | 151 | 0.220 |
Why?
|
Recovery of Function | 1 | 2025 | 264 | 0.210 |
Why?
|
Bayes Theorem | 1 | 2023 | 106 | 0.210 |
Why?
|
Cardiovascular System | 1 | 2023 | 41 | 0.210 |
Why?
|
Heart Ventricles | 1 | 2024 | 251 | 0.200 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 1379 | 0.190 |
Why?
|
Cumulus Cells | 1 | 2021 | 6 | 0.190 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 122 | 0.190 |
Why?
|
Manufacturing Industry | 1 | 2021 | 4 | 0.180 |
Why?
|
Neural Stem Cells | 1 | 2021 | 43 | 0.180 |
Why?
|
Drug Delivery Systems | 2 | 2023 | 310 | 0.180 |
Why?
|
Diffusion | 3 | 2021 | 84 | 0.180 |
Why?
|
Materials Testing | 3 | 2019 | 79 | 0.180 |
Why?
|
Models, Neurological | 1 | 2021 | 81 | 0.180 |
Why?
|
International Cooperation | 1 | 2021 | 81 | 0.180 |
Why?
|
Policy | 1 | 2021 | 48 | 0.180 |
Why?
|
Noninvasive Ventilation | 1 | 2021 | 70 | 0.170 |
Why?
|
Heart | 2 | 2014 | 276 | 0.170 |
Why?
|
Splanchnic Circulation | 1 | 2020 | 15 | 0.170 |
Why?
|
Mesentery | 1 | 2020 | 14 | 0.170 |
Why?
|
Polymers | 2 | 2013 | 317 | 0.170 |
Why?
|
Blepharoptosis | 2 | 2017 | 4 | 0.170 |
Why?
|
Extracellular Fluid | 1 | 2019 | 11 | 0.160 |
Why?
|
Xenobiotics | 1 | 2019 | 13 | 0.160 |
Why?
|
Drug Carriers | 1 | 2021 | 175 | 0.160 |
Why?
|
Coculture Techniques | 1 | 2018 | 94 | 0.150 |
Why?
|
Equipment Design | 3 | 2020 | 317 | 0.150 |
Why?
|
Numerical Analysis, Computer-Assisted | 2 | 2015 | 6 | 0.150 |
Why?
|
Pericytes | 1 | 2018 | 15 | 0.150 |
Why?
|
Kinetics | 3 | 2021 | 735 | 0.150 |
Why?
|
Optogenetics | 1 | 2018 | 21 | 0.150 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 138 | 0.150 |
Why?
|
Respiration, Artificial | 1 | 2021 | 294 | 0.150 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 102 | 0.150 |
Why?
|
Blinking | 2 | 2017 | 4 | 0.140 |
Why?
|
Coronavirus Infections | 1 | 2020 | 187 | 0.140 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 199 | 0.140 |
Why?
|
Nanoparticles | 2 | 2021 | 499 | 0.140 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 69 | 0.140 |
Why?
|
Mechanotransduction, Cellular | 1 | 2017 | 26 | 0.140 |
Why?
|
Coronary Circulation | 2 | 2014 | 50 | 0.130 |
Why?
|
Cattle | 1 | 2017 | 306 | 0.130 |
Why?
|
Suture Techniques | 1 | 2017 | 86 | 0.130 |
Why?
|
Coronary Vessels | 2 | 2014 | 109 | 0.130 |
Why?
|
Liver | 1 | 2019 | 788 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 155 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2014 | 13 | 0.110 |
Why?
|
Mice, Transgenic | 1 | 2018 | 1225 | 0.110 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 88 | 0.110 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2013 | 9 | 0.110 |
Why?
|
Sutures | 1 | 2013 | 33 | 0.110 |
Why?
|
Biomimetic Materials | 1 | 2013 | 35 | 0.110 |
Why?
|
Mouth Neoplasms | 1 | 2013 | 32 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 115 | 0.110 |
Why?
|
Cell Death | 1 | 2014 | 272 | 0.110 |
Why?
|
Video Recording | 1 | 2013 | 126 | 0.100 |
Why?
|
Fibroblasts | 1 | 2014 | 370 | 0.100 |
Why?
|
Cell Line | 1 | 2017 | 2015 | 0.100 |
Why?
|
Head and Neck Neoplasms | 1 | 2013 | 153 | 0.100 |
Why?
|
Glucuronic Acid | 1 | 2011 | 18 | 0.100 |
Why?
|
Hexuronic Acids | 1 | 2011 | 22 | 0.100 |
Why?
|
Alginates | 1 | 2011 | 44 | 0.090 |
Why?
|
Lactic Acid | 1 | 2011 | 70 | 0.090 |
Why?
|
Child | 1 | 2020 | 4324 | 0.090 |
Why?
|
Cells, Cultured | 2 | 2014 | 2100 | 0.090 |
Why?
|
Porosity | 3 | 2019 | 38 | 0.090 |
Why?
|
Cell Differentiation | 1 | 2015 | 1297 | 0.080 |
Why?
|
Capillary Permeability | 1 | 2008 | 14 | 0.080 |
Why?
|
Glucose | 1 | 2011 | 446 | 0.080 |
Why?
|
Tensile Strength | 2 | 2019 | 28 | 0.070 |
Why?
|
Diabetic Retinopathy | 1 | 2024 | 45 | 0.060 |
Why?
|
Biomarkers | 1 | 2009 | 1205 | 0.050 |
Why?
|
Respiratory System | 1 | 2023 | 42 | 0.050 |
Why?
|
Heart Rate | 1 | 2023 | 306 | 0.050 |
Why?
|
Cell Movement | 1 | 2024 | 424 | 0.050 |
Why?
|
Macular Degeneration | 1 | 2024 | 179 | 0.050 |
Why?
|
Female | 5 | 2024 | 31095 | 0.050 |
Why?
|
Myocardium | 2 | 2014 | 263 | 0.040 |
Why?
|
Neurites | 1 | 2019 | 22 | 0.040 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 163 | 0.040 |
Why?
|
Tendons | 1 | 2019 | 21 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2019 | 105 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2021 | 523 | 0.040 |
Why?
|
Diphosphates | 1 | 2018 | 10 | 0.040 |
Why?
|
PC12 Cells | 1 | 2018 | 25 | 0.040 |
Why?
|
Transplants | 1 | 2018 | 9 | 0.040 |
Why?
|
Nerve Transfer | 1 | 2018 | 6 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2018 | 22 | 0.040 |
Why?
|
Ibuprofen | 1 | 2018 | 18 | 0.040 |
Why?
|
Acetaminophen | 1 | 2019 | 52 | 0.040 |
Why?
|
Betacoronavirus | 1 | 2020 | 160 | 0.040 |
Why?
|
Stilbenes | 1 | 2018 | 46 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2018 | 179 | 0.040 |
Why?
|
Blood Vessels | 1 | 2018 | 61 | 0.040 |
Why?
|
Mice, Nude | 1 | 2018 | 260 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 252 | 0.040 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 223 | 0.040 |
Why?
|
Drug Discovery | 1 | 2018 | 92 | 0.040 |
Why?
|
Gadolinium | 1 | 2018 | 102 | 0.040 |
Why?
|
Hepatocytes | 1 | 2019 | 194 | 0.040 |
Why?
|
Glioma | 1 | 2018 | 102 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2018 | 176 | 0.030 |
Why?
|
Pregnancy | 1 | 2024 | 2359 | 0.030 |
Why?
|
Forehead | 1 | 2017 | 19 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 200 | 0.030 |
Why?
|
Adult | 3 | 2021 | 15882 | 0.030 |
Why?
|
Middle Aged | 3 | 2021 | 16400 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 22 | 0.030 |
Why?
|
Contrast Media | 1 | 2018 | 414 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 259 | 0.030 |
Why?
|
Cell Aggregation | 1 | 2014 | 21 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 168 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2014 | 60 | 0.030 |
Why?
|
Anisotropy | 1 | 2014 | 59 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2014 | 26 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2014 | 43 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
Aminopyridines | 1 | 2014 | 23 | 0.030 |
Why?
|
Neurons | 1 | 2019 | 860 | 0.030 |
Why?
|
Quinolines | 1 | 2014 | 38 | 0.030 |
Why?
|
Hardness | 1 | 2013 | 8 | 0.030 |
Why?
|
Compressive Strength | 1 | 2013 | 18 | 0.030 |
Why?
|
Oculomotor Muscles | 1 | 2013 | 10 | 0.030 |
Why?
|
Rhodamines | 1 | 2013 | 20 | 0.030 |
Why?
|
Morpholines | 1 | 2014 | 85 | 0.030 |
Why?
|
Clathrin | 1 | 2013 | 23 | 0.030 |
Why?
|
Imidazoles | 1 | 2014 | 83 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 73 | 0.030 |
Why?
|
Muscles | 1 | 2014 | 171 | 0.030 |
Why?
|
Stochastic Processes | 1 | 2013 | 26 | 0.030 |
Why?
|
Signal Transduction | 2 | 2014 | 2890 | 0.030 |
Why?
|
Nanomedicine | 1 | 2013 | 24 | 0.030 |
Why?
|
Aged | 2 | 2021 | 13461 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2016 | 278 | 0.030 |
Why?
|
Culture Media | 1 | 2013 | 77 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 170 | 0.030 |
Why?
|
Male | 3 | 2021 | 27766 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2014 | 186 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 3204 | 0.020 |
Why?
|
Young Adult | 1 | 2021 | 4363 | 0.020 |
Why?
|
Pilot Projects | 1 | 2013 | 927 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2009 | 22 | 0.020 |
Why?
|
Physics | 1 | 2009 | 12 | 0.020 |
Why?
|
Hemorheology | 1 | 2008 | 6 | 0.020 |
Why?
|
Biology | 1 | 2009 | 25 | 0.020 |
Why?
|
Extracellular Space | 1 | 2008 | 30 | 0.020 |
Why?
|
Time Factors | 1 | 2015 | 3590 | 0.020 |
Why?
|